Key Takeaways From the 2026 AVA Clinical Practice Guidelines

The Association for Vascular Access (AVA)—a global organization dedicated to advancing the practice of vascular access through education, research, and clinical standards—recently released the 2026 AVA Clinical Practice Guidelines (CPG) for Adults, establishing a comprehensive, evidence-informed resource for vascular access care across all clinical settings.

CIVCO Medical Solutions is proud to support AVA and vascular access education. The guidelines address the full lifecycle of vascular access devices (VADs) for adults patients —from infrastructure and patient assessment to device selection, insertion, ongoing care, complication management, and removal.

Let’s dive into some of the key highlights and strategic imperatives outlined in the guidelines.

Key Highlights & Strategic Imperatives

The 2026 AVA Clinical Practice Guidelines include vein visualization as a clinical consideration during vascular access insertion and highlight special considerations for patients with difficult intravenous access (DIVA). The Guidelines’ recommendations apply across multiple device types—including peripheral intravenous catheters (PIVCs), central venous access devices (CVADs), and arterial catheters—reinforcing the importance of technologies that improve vein identification and insertion success.

Importantly, the guidelines also emphasize that education, competency, and organizational infrastructure are also foundational to safe vascular access practice. The guidelines call for a reduction in unwarranted variation in practice, dedicated vascular access teams, and ongoing, accurate data collection.

2. Unwavering Commitment to Infection Prevention

Infection prevention remains central to the AVA framework. The guidelines integrate infection control into every stage of the vascular access lifecycle—not just insertion.

Core principles reinforced include:

• Strict hand hygiene adherence
• Aseptic Non-Touch Technique (ANTT)
• Maximal Sterile Barrier (MSB) precautions for central line insertions
• Use of alcohol-based chlorhexidine gluconate (CHG) for skin antisepsis

For ultrasound-guided procedures, the guidelines specifically call for:

• Sterile probe covers
• Sterile gel during insertion
• Appropriate probe disinfection between patients per manufacturer instructions and institutional policy

The document also highlights the importance of infection prevention infrastructure, including:

• Standardized policies and checklists
• Documentation protocols
• Infection surveillance systems

Infection prevention is framed not as an isolated practice, but as an organizational accountability priority requiring alignment between clinicians, infection preventionists, and leadership.

3. Enhanced Best Practices for Device Management

A significant advancement in the 2026 guidelines is the emphasis on device stewardship—recognizing that complications are often linked not just to insertion technique, but to ongoing device management.

Evidence-Based Device Selection

The guidelines outline structured criteria for selecting the appropriate VAD based on:

• Infusate characteristics
• Anticipated duration
• Patient anatomy and physiology
• Emergent vs. planned access needs
• Material and design

This reinforces that vascular access planning must be intentional—not reactive.

Catheter Length & Stabilization

For PIVCs and other VADs, the guidelines emphasize:

• Adequate in-vessel catheter length to reduce dislodgement and failure
• Appropriate securement and stabilization devices

4. Organizational and Educational Recommendations

The 2026 AVA Guidelines make clear that successful implementation requires system-level infrastructure.

Dedicated Vascular Access Teams (VATs)

The guidelines recommend consideration of dedicated VATs to:

• Reduce complications from CLABSIs and peripheral IV catheter failure
• Higher success rates during difficult insertions
• Fewer insertion attempts
• Greater procedural accuracy during VAD insertion
• Improved patient flow
• Lower health care expenditures
• Timely care delivery

Policy, Protocol, and EHR Integration

AVA also calls for:

• Standardized organizational policies
• Integration of surveillance tools within the Electronic Health Record (EHR)
• Frameworks that capture device necessity and monitoring
• Accurate, systematic data collection

Continuous Education & Competency

The guidelines emphasize:

• Ongoing education beyond initial training
• Structured competency validation
• Interprofessional rounding and collaboration

This reflects AVA’s recognition that vascular access care is multidisciplinary and must align across nursing, physicians, advanced practice providers, infection prevention, and quality teams.

Conclusion

The 2026 AVA Clinical Practice Guidelines for Adults provide a comprehensive roadmap for advancing vascular access care across healthcare systems, integrating:

• Structured infection prevention protocols
• Evidence-based device selection and management
• Organizational infrastructure and education

At CIVCO Medical Solutions, our mission is centered on Improving Patient Outcomes, and we are proud to support healthcare organizations working to implement evidence-based vascular access practices. Through solutions that support infection prevention, ultrasound-guided vascular access, and clinician education, CIVCO is committed to helping clinical teams translate guideline recommendations into safer, more consistent patient care.

References:

#1: The Journal of the Association for Vascular Access – Clinical Practice Guidelines for Adults - 2026

COPYRIGHT © 2026. ALL RIGHTS RESERVED. CIVCO IS A REGISTERED TRADEMARK OF CIVCO MEDICAL SOLUTIONS. ALL OTHER TRADEMARKS ARE THE PROPERTY OF THEIR RESPECTIVE OWNERS. PRINTED IN USA. 2026M-3478 REV. 1